author-photo

Berend Neuteboom

Merck Serono

10

Papers

503

Citations

Citation Trend

Filter By

Papers (7) Sort By

Journal Conference Others

195 Avelumab internalization and lysosomal degradation by circulating immune cells in human is mediated by both Fc gamma Receptor (FcgR) and PD-L1 binding

2020 Journal for ImmunoTherapy of Cancer
Show All
- Source
- Cite
- Save
Citations (2)
Avelumab for metastatic or locally advanced previously treated solid tumours (JAVELIN Solid Tumor): a phase 1a, multicohort, dose-escalation trial

2017 Lancet Oncology
Show All
- Source
- Cite
- Save
Citations (181)
Pharmacokinetic profile and receptor occupancy of avelumab (MSB0010718C), an anti-PD-L1 monoclonal antibody, in a phase I, open-label, dose escalation trial in patients with advanced solid tumors.

2015 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (15)
A generic approach to engineer antibody pH-switches using combinatorial histidine scanning libraries and yeast display

2015 mAbs
Show All
- Source
- Cite
- Save
Citations (41)
8PDPhase I JAVELIN solid tumor trial of avelumab (MSB0010718C), an anti-PD-L1 antibody: Safety and pharmacokinetics

2015 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (3)
Therapeutic assessment of SEED: a new engineered antibody platform designed to generate mono- and bispecific antibodies

2011 Protein Engineering Design & Selection
Show All
- Source
- Cite
- Save
Citations (41)
Radiation sensitization of glioblastoma by cilengitide has unanticipated schedule‐dependency

2009 International Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (113)